Carisma Therapeutics, Inc.CARMNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank92
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-0.29
↑ 99% vs avg
Percentile
P92
Near historical high
Streak
3 yr
Consecutive growthElevated
Average
-44.19
Historical baseline
PeriodValueYoY Change
2024-0.29+74.6%
2023-1.13+85.9%
2022-8.02+98.2%
2021-442.23-7755.4%
2020-5.63-540.0%
2019-0.88+66.2%
2018-2.60-257.1%
2017-0.73-103.4%
201621.29+1345.9%
2015-1.71-